| Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies S Eriksson, EH Graf, V Dahl, MC Strain, SA Yukl, ES Lysenko, RJ Bosch, ... PLoS pathogens 9 (2), e1003174, 2013 | 670 | 2013 |
| HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ... Nature medicine 16 (4), 460-465, 2010 | 656 | 2010 |
| Chlamydia trachomatis infection and persistence of human papillomavirus I Silins, W Ryd, A Strand, G Wadell, S Törnberg, BG Hansson, X Wang, ... International journal of cancer 116 (1), 110-115, 2005 | 246 | 2005 |
| A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response H Hatano, TL Hayes, V Dahl, E Sinclair, TH Lee, R Hoh, H Lampiris, ... The Journal of infectious diseases 203 (7), 960-968, 2011 | 234 | 2011 |
| Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation V Dahl, J Peterson, D Fuchs, M Gisslen, S Palmer, RW Price Aids 28 (15), 2251-2258, 2014 | 165 | 2014 |
| The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial PW Hunt, NS Shulman, TL Hayes, V Dahl, M Somsouk, NT Funderburg, ... Blood, The Journal of the American Society of Hematology 121 (23), 4635-4646, 2013 | 155 | 2013 |
| HIV reservoirs, latency, and reactivation: prospects for eradication V Dahl, L Josefsson, S Palmer Antiviral research 85 (1), 286-294, 2010 | 153 | 2010 |
| Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study JM Llibre, MJ Buzón, M Massanella, A Esteve, V Dahl, MC Puertas, ... Antiviral therapy 17 (2), 355-364, 2012 | 143 | 2012 |
| Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected C Gutiérrez, L Díaz, A Vallejo, B Hernández-Novoa, M Abad, N Madrid, ... PloS one 6 (12), e27864, 2011 | 117 | 2011 |
| Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal V Dahl, L Mellhammar, F Bajunirwe, P Björkman AIDS care 20 (6), 746-752, 2008 | 85 | 2008 |
| Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy V Dahl, E Lee, J Peterson, SS Spudich, I Leppla, E Sinclair, D Fuchs, ... The Journal of infectious diseases 204 (12), 1936-1945, 2011 | 75 | 2011 |
| An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy V Dahl, M Gisslen, L Hagberg, J Peterson, W Shao, S Spudich, RW Price, ... The Journal of infectious diseases 209 (10), 1618-1622, 2014 | 63 | 2014 |
| Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register V Dahl, KT Wisell, CG Giske, A Tegnell, A Wallensten Eurosurveillance 24 (20), 2019 | 26 | 2019 |
| Communicable diseases prioritized according to their public health relevance, Sweden, 2013 V Dahl, A Tegnell, A Wallensten PLoS One 10 (9), e0136353, 2015 | 26 | 2015 |
| Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers V Dahl, J Peterson, S Spudich, E Lee, BL Shacklett, RW Price, S Palmer Aids 27 (7), 1145-1149, 2013 | 26 | 2013 |
| Can HIV infection be eradicated through use of potent antiviral agents? L Josefsson, V Dahl, S Palmer Current opinion in infectious diseases 23 (6), 628-632, 2010 | 26 | 2010 |
| A nationwide outbreak of listeriosis associated with cold-cuts, Sweden 2013-2014 V Dahl, L Sundqvist, I Hedenström, M Löfdahl, E Alm, H Ringberg, ... Infection ecology & epidemiology 7 (1), 1324232, 2017 | 21 | 2017 |
| Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013 V Dahl, A Wallensten PLoS One 12 (7), e0181625, 2017 | 20 | 2017 |
| Establishment of drug-resistant HIV-1 in latent reservoirs V Dahl, S Palmer The Journal of infectious diseases 199 (9), 1258-1260, 2009 | 19 | 2009 |
| Multi-country outbreak of Salmonella enteritidis infection linked to the international ice hockey tournament T Pärn, V Dahl, T Lienemann, J Perevosčikovs, B De Jong Epidemiology & Infection 145 (11), 2221-2230, 2017 | 17 | 2017 |
